The project results are expected to contribute to the following outcomes: support for the development of EU production of stable isotopes that are essential for the manufacturing of radionuclides used in novel nuclear medicine therapies; strengthening of the resilience and security of the EU medical radioisotope supply chain by securing access to source materials, reducing dependence on third countries and enhancing industrial-scale production (including the sourcing of stable isotopes); leveraging of the knowledge and expertise of nuclear scientists, physicists and engineers in order to develop and optimise the processes for the EU-based production of stable isotopes, while contributing to Europe’s Beating Cancer Plan and implementing the Strategic Agenda for Medical Ionising Radiation Applications (SAMIRA).
- Scadenza
- 15/09/2026, 00:00(34 gg)
- Importo
- 2.000.000 €
- Contributo
- non specificato
- Territorio
- EU
Fonte: EU Funding & Tenders Portal (+3 altre) · controllata il 07/08/2026 · affidabilita' 85%
Da verificare sul bando: chi puo' partecipare.